This is the authors' abstract. We don't add key points for this paper.
Herein we describe the identification of 4-{[1,2,4]triazolo[1,5- a ]pyridin-5-yl}benzonitrile-based inhibitors of the hypoxia-inducible factor prolylhydroxylase domain-1 (PHD-1) enzyme. These inhibitors were shown to possess a novel binding mode by X-ray crystallography, in which the triazolo N1 atom coordinates in a hitherto unreported monodentate interaction with the active site Fe 2+ ion, while the benzonitrile group accepts a hydrogen-bonding interaction from the side chain residue of Asn315. Further optimization led to potent PHD-1 inhibitors with good physicochemical and pharmacokinetic properties.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Ahmed et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: